Breaking News Instant updates and real-time market news.

CMCSA

Comcast

$33.13

-0.43 (-1.28%)

, CMCSK

Comcast

$58.00

(0.00%)

09:06
04/13/18
04/13
09:06
04/13/18
09:06

Netflix, Comcast announce expansion of Netflix-Xfinity packages

Comcast (CMCSA, CMCSK) and Netflix (NFLX) announced an expansion of their partnership that will provide Comcast the ability to include a Netflix subscription in new and existing Xfinity packages. The companies said: "In 2016, Comcast launched Netflix on the X1 platform, offering customers a fully integrated entertainment experience featuring voice control and seamless access to the Netflix service. Netflix has quickly become one of the most popular voice searches and highly-viewed services on the platform; and among households watching Netflix on X1, X1 has quickly become the most used platform for Netflix viewing. Comcast has integrated the Netflix service with the X1 user experience, enabling customers to easily browse and access the entire Netflix service, including TV shows, films, documentaries, stand-up comedy, kid's titles and a catalog of Ultra HD 4K and HDR programming-alongside the live, on demand, DVR and web video from hundreds of networks, studios and digital brands available with their Xfinity TV subscription. Comcast will launch a variety of initial offers this month that include a Netflix subscription. Offers and availability will vary by market and be open to new and existing customers. Netflix-related billing will be handled directly by Comcast, giving customers one monthly statement."

CMCSA

Comcast

$33.13

-0.43 (-1.28%)

CMCSK

Comcast

$58.00

(0.00%)

NFLX

Netflix

$309.25

5.58 (1.84%)

  • 16

    Apr

  • 25

    Apr

CMCSA Comcast
$33.13

-0.43 (-1.28%)

03/26/18
COWN
03/26/18
INITIATION
COWN
Market Perform
Comcast initiated with a Market Perform at Cowen
03/15/18
LOOP
03/15/18
INITIATION
Target $43
LOOP
Buy
21st Century Fox initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started 21st Century Fox (FOXA) with a Buy rating and $43 price target. The analyst believes the company is set up as the "ideal acquisition target for either Disney (DIS) or Comcast (CMCSA) as they evolve their video businesses into a global, direct-to-consumer streaming service."
04/09/18
NOMU
04/09/18
NO CHANGE
Target $40
NOMU
Neutral
Comcast price target lowed to $40 from $45 at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal lowered his price target for Comcast shares to $40 to reflect reduced buyback expectations. The analyst, however, says the "sky is not falling." The analyst, while continuing to prefer mobile over fixed, views the 15% pullback in Comcast shares as an overreaction. He expects the company to offer investors "some relief" on its Q1 call. Kvaal keeps a Neutral rating on Comcast.
04/02/18
MACQ
04/02/18
NO CHANGE
Target $38
MACQ
Neutral
Macquarie sees Q1 video losses for Comcast
Macquarie analyst Amy Yong is modeling Comcast Q1 video net losses of 77k and revenue declines of .7% due to lower video net adds/ARPU. Yong expects downward estimate revisions for Comcast given headwinds to the video business and uncertainty around its interest in Sky and lowered her 2018/19 consolidated EBITDA to $29.2B and $31.2B, respectively. The analyst rates shares of Comcast a Neutral and cut her price target to $38 from $42.
CMCSK Comcast
$58.00

(0.00%)

02/27/18
RBCM
02/27/18
NO CHANGE
RBCM
RBC says 21st Century Fox may let Comcast go ahead without counter-bid for Sky
After Comcast (CMCSA) proposed a cash offer for Sky (SKYAY) at a 16% premium to 21st Century Fox's (FOX) existing takeover bid, RBC Capital analyst Steven Cahall said that while he does not "profess to know the minds of the Murdochs" on the matter, he is inclined to think that Fox may let Comcast go ahead with its bid as the deal will no longer be "financially opportunistic" as it would have been. Adding that he was surprised Disney's (DIS) original deal for Fox included the Sky stake, Cahall said he's also "inclined to say" that Disney management "can live without Sky" and that the story is "unchanged, and arguably cleaner," without Sky. The analyst, who contends that Disney and Fox are best off letting Comcast "swoop in on Sky," has a Top Pick rating on Disney and an Outperform rating on 21st Century Fox.
03/14/18
MACQ
03/14/18
UPGRADE
MACQ
Outperform
Sky upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Guy Peddy upgraded Sky (SKYAY) to Outperform from Neutral after he raised his FY19/20 and FY20/21 EPS by about 16% due to the lower EPL costs. His valuation analysis suggests the current 1075p offer from 21st Century Fox (FOXA) "materially undervalues" Sky and even Comcast's (CMCSA) indicative offer at 1250p "fractionally undervalues" it, Peddy tells investors. What happens next is up to Comcast and Disney (DIS), as Fox is just an intermediary, he added. Peddy raised his price target on Sky shares to 1450p, as he believes tension between those two could lift the offer price at least 10% above his fair value estimate of 1287p.
03/07/18
WELS
03/07/18
NO CHANGE
WELS
Wells Fargo expects bidding war for Sky
Wells Fargo analyst Marci Ryvicker expects a bidding war for Sky (SKYAY). The analyst believes Sky appears to be more accretive to Disney (DIS)-Fox (FOXA) but more strategic for Comcast (CMCSA; CMCSK). Ultimately, Ryvicker thinks the latter with win but not without a fight from Disney/Fox.
02/28/18
02/28/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Celgene (CELG) downgraded to Hold from Buy at SunTrust by analyst Yatin Suneja after the company received a refusal to file letter from the FDA on ozanimod for relapsing forms of multiple sclerosis. Suneja said that following pipeline setbacks in late 2017, ozanimod was central to his "bull thesis to re-accelerate growth" and provide "much needed diversification away from myeloma." Given the delay, he lowered his ozanimod peak sales estimate to $3.5B from $5B. The refusal to file letter could result in a 24-month or longer delay for ozanimod's launch in relapsing forms of multiple sclerosis, Suneja said. 2. Frontier Communications (FTR) downgraded to Hold from Buy at Jefferies by analyst Scott Goldman. With the dividend now suspended and EBITDA stabilization "still a work in progress," the shares have no near-term catalyst, Goldman said. He believes "significant challenges" remain for Frontier following the dividend suspension. 3. Comcast (CMCSA, CMCSK) downgraded to Neutral from Outperform at Macquarie by analyst Amy Young, who cited uncertainty around the M&A playbook and increased net leverage. Young said Comcast's intention to acquire Sky (SKYAY) diversifies its portfolio and increases international revenues to 25% of total from 9% currently, but exposes it to satellite TV, which faces secular pressures. The analyst views the 12x price tag for Sky as high, questions the synergies, and believes the unpredictability could cap near-term upside. 4. e.l.f. Beauty (ELF) downgraded to Market Perform from Outperform at BMO Capital by analyst Shannon Coyne, who cited the "near-term challenges in the mass category" and heightened competition yielding further pressure on results and the stock in the near term. The analyst also points to the management having lowered its expectations for the 3rd time in 6 months, adding that it may take some time for investor confidence to return. Despite the downgrade, the analyst believes that e.l.f "has material white space in existing and new retailers" as well as an "unmatched strong value proposition." 5. Maxim Integrated (MXIM) downgraded to Neutral from Outperform at Macquarie by analyst Srini Pajjuri, who said shares have significantly outperformed the SOX index year-to-date and believes healthy fundamentals are now backed in, combined with some M&A premium. Pajjuri believes further upside is limited on a fundamental basis and believes comps will get tougher in the second half of 2018 and sees risk of higher volatility in Consumer as Samsung GS9 builds fade. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NFLX Netflix
$309.25

5.58 (1.84%)

04/13/18
DBAB
04/13/18
UPGRADE
Target $350
DBAB
Buy
Deutsche Bank upgrades Netflix to Buy with price target of $350
Deutsche Bank analyst Bryan Kraft upgraded Netflix to Buy from Hold and raised his price target for the shares to $350 from $240. The streaming service closed yesterday up $5.58 to $309.25. The analyst admits he underestimated the market's willingness to underwrite several years of negative free cash flow to drive growth. Netflix has changed the industry in a "profound way" and in doing so has given itself a "significant" lead, making it very difficult for the traditional media companies, or even other big tech companies, to catch up, Kraft tells investors in a research note. He believes Netflix continues to capitalize on this lead by reinvesting in content, marketing, and the user experience. Further, the company's Q1 guidance looks conservative by up to 1M subscribers worldwide, the analyst contends.
04/13/18
WELS
04/13/18
NO CHANGE
Target $345
WELS
Outperform
Netflix price target raised to $345 from $285 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Netflix to $345 from $285 saying his survey of 500 U.S. residents reaffirms the streaming service's pricing power. The survey indicates that based on the level and quality of content Netflix has today, 50% of respondents would pay a higher, and in some instances a much higher, price, Sena tells investors in a research note. The analyst modestly increased his outer-year estimates for Netflix and keeps an Outperform rating on the shares.
04/13/18
DBAB
04/13/18
UPGRADE
DBAB
Buy
Netflix upgraded to Buy from Hold at Deutsche Bank
04/12/18
KEYB
04/12/18
NO CHANGE
Target $300
KEYB
Overweight
Growing spending should drive upside to Netflix Q1 subscriber estimates, says KeyBanc
KeyBanc analyst Andy Hargreaves says that an analysis of Netflix's ability to drive subscriber growth through marketing and content spending suggests the potential for upside to our subscriber estimates in Q1 and 2018, and suggests a business with substantial profit potential and growing barriers to entry. The analyst reiterates an Overweight rating and $300 price target on the shares.

TODAY'S FREE FLY STORIES

SVXY

ProShares Short VIX Short-Term Futures

$13.79

0.08 (0.58%)

06:54
07/16/18
07/16
06:54
07/16/18
06:54
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROX

Tronox

$19.31

-0.28 (-1.43%)

, VNTR

Venator Materials

$16.76

0.07 (0.42%)

06:54
07/16/18
07/16
06:54
07/16/18
06:54
Hot Stocks
Tronox, Venator Materials agree to divest 8120 paper-laminate product grade »

Tronox (TROX) announced…

TROX

Tronox

$19.31

-0.28 (-1.43%)

VNTR

Venator Materials

$16.76

0.07 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 08

    Aug

XERS

Xeris Pharmaceuticals

$18.26

-0.18 (-0.98%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Initiation
Xeris Pharmaceuticals initiated  »

Xeris Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INST

Instructure

$44.93

-0.225 (-0.50%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Initiation
Instructure initiated  »

Instructure initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 30

    Jul

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Hot Stocks
Bank of America CEO says solid operating leverage drove earnings in Q2 »

Brian Moynihan, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

USO

United States Oil Fund

$14.47

0.085 (0.59%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Technical Analysis
United States Oil Fund: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIIV

i3 Verticals

$16.73

-0.025 (-0.15%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Initiation
i3 Verticals initiated  »

i3 Verticals initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$17.14

0.08 (0.47%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Conference/Events
Krystal Biotech management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 25

    Jul

XOP

SPDR Oil Exploration and Production Fund

$43.19

0.06 (0.14%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Hot Stocks
Bank of America reports Q2 average loan balances in business segments up 5% »

Average loan balances in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$26.43

0.89 (3.48%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$102.95

0.17 (0.17%)

, TEVA

Teva

$23.29

-0.45 (-1.90%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Recommendations
Neurocrine, Teva analyst commentary  »

Neurocrine price target…

NBIX

Neurocrine

$102.95

0.17 (0.17%)

TEVA

Teva

$23.29

-0.45 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

  • 16

    Sep

UGAZ

VelocityShares 3x Long Natural Gas ETN

$54.61

-2.06 (-3.64%)

06:50
07/16/18
07/16
06:50
07/16/18
06:50
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:50
07/16/18
07/16
06:50
07/16/18
06:50
Hot Stocks
Bank of America reports Q2 NII up 6% to $11.7B »

Reflecting benefits from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

ERJ

Embraer

$21.50

-0.78 (-3.50%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Periodicals
Embraer sees demand for 10,550 smaller jets in next 20 years, Reuters reports »

Brazil's Embraer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

EPRT

Essential Properties Realty Trust

$14.00

(0.00%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Initiation
Essential Properties Realty Trust initiated  »

Essential Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$34.05

0.67 (2.01%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNTR

Venator Materials

$16.76

0.07 (0.42%)

, TROX

Tronox

$19.31

-0.28 (-1.43%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Hot Stocks
Venator Materials to acquire European paper laminates business from Tronox »

Venator Materials (VNTR)…

VNTR

Venator Materials

$16.76

0.07 (0.42%)

TROX

Tronox

$19.31

-0.28 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 08

    Aug

PSA

Public Storage

$228.07

-1.43 (-0.62%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Downgrade
Public Storage rating change  »

Public Storage downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EFA

iShares MSCI EAFE Index Fund

$67.80

0.21 (0.31%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Hot Stocks
Bank of America reports Q2 return on average assets 1.17% »

Reports Q2 return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

BRO

Brown & Brown

$28.76

0.025 (0.09%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Hot Stocks
Brown & Brown subsidiary acquires Professional Disability Associates »

J. Scott Penny, Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JNK

SPDR Barclays High Yield Bond

$35.69

(0.00%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$20.45

-0.11 (-0.54%)

06:47
07/16/18
07/16
06:47
07/16/18
06:47
Conference/Events
Intra-Cellular management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SJB

ProShares Short High Yield

$22.95

-0.055 (-0.24%)

06:47
07/16/18
07/16
06:47
07/16/18
06:47
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.